Alexion Pharma GmbH - Strensiq 100 mg/ml, Injektionslösung |
| 66086 | | 02 | | Strensiq 100 mg/ml | | Injektionslösung | | A16AB13 | | Asfotase Alfa | | 16.08.2016 | | |
|
Composition |
asfotasum alfa 100 mg, natrii chloridum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
Packungsbestandteile |
| Solution injectable | | | | Principe actif | Concentr. |
---|
Asfotasum Alfa | 100 mg/ml |
| | Agents auxilliaires |
---|
Disodium Phosphate Heptahydrate | Sodium Chlorure | Sodium Dihydrogenophosphate Monohydrate |
|
|
|